Skip to main navigation
Skip to search
Skip to main content
Discovery - the University of Dundee Research Portal Home
Home
Profiles
Research units
Research Outputs
Projects
Datasets
Theses
Activity
Press/Media
Research Facilities
Prizes
Search by expertise, name or affiliation
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis
Susan Wyllie
,
Michael Thomas
, Stephen Patterson
, Sabrinia Crouch
,
Manu De Rycker
, Rhiannon Lowe
, Stephanie Gresham
, Michael D. Urbaniak
, Thomas D. Otto
,
Laste Stojanovski
,
Frederick R. C. Simeons
, Sujatha Manthri
,
Lorna M. MacLean
, Fabio Zuccotto
, Nadine Homeyer
, Hannah Pflaumer
, Markus Boesche
, Lalitha Sastry
, Paul Connolly
, Sebastian Albrecht
Matt Berriman, Gerard Drewes,
David W. Gray
, Sonja Ghidelli-Disse, Susan Dixon, Jose M. Fiandor, Paul G. Wyatt,
Michael A. J. Ferguson
,
Alan H. Fairlamb
, Timothy J. Miles (Lead / Corresponding author),
Kevin D. Read
(Lead / Corresponding author),
Ian H. Gilbert
(Lead / Corresponding author)
Show 12 more
Show less
Drug Discovery Unit
Biological Chemistry and Drug Discovery
Research output
:
Contribution to journal
›
Article
›
peer-review
133
Citations (Scopus)
1116
Downloads (Pure)
Overview
Fingerprint
Projects
(5)
Research Outputs
(1)
Profiles
(1)
Fingerprint
Dive into the research topics of 'Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Antileishmanial
25%
Cyclin-dependent Kinase 12
100%
Drug Target
100%
Drug-like
25%
Druggable Targets
25%
Effective Treatment
25%
Further Development
25%
Mode of Action
25%
Mouse Model
25%
Pharmacokinetic Properties
25%
Physicochemical Properties
25%
Preclinical Candidate
25%
Toxicological Properties
25%
Triazolopyrimidine
25%
Visceral Leishmaniasis
100%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclin Dependent Kinase
100%
Diseases
25%
Mouse Model
25%
Pharmacokinetics
25%
Phosphotransferase
25%
Pyrazolopyrimidine
25%
Visceral Leishmaniasis
100%